His primary scientific interests are in Molecular biology, Cancer research, Cell growth, Cell biology and Cell culture. Bruno Calabretta has researched Molecular biology in several fields, including Haematopoiesis and Complementary DNA, MYB, Gene expression, Gene. The Cancer research study combines topics in areas such as Apoptosis, ABL, Chronic myelogenous leukemia, Leukemia and breakpoint cluster region.
His biological study spans a wide range of topics, including Protein biosynthesis, K562 cells, Philadelphia chromosome and Untranslated region. His research integrates issues of Phenotype, Cell cycle and In vitro in his study of Cell growth. His Cell biology research incorporates themes from Cyclin B, Cyclin A and Cyclin D.
Molecular biology, Cancer research, Cell biology, Haematopoiesis and Cell culture are his primary areas of study. His Molecular biology research is multidisciplinary, incorporating perspectives in Gene expression, Cellular differentiation, Messenger RNA, Gene and MYB. His Cancer research study combines topics from a wide range of disciplines, such as ABL, Chronic myelogenous leukemia, Leukemia, Stem cell and breakpoint cluster region.
His study in breakpoint cluster region is interdisciplinary in nature, drawing from both Tyrosine kinase and Philadelphia chromosome. The concepts of his Cell biology study are interwoven with issues in Cell cycle, Apoptosis and Transfection. His Cell culture research is multidisciplinary, relying on both Cell growth and Sense.
Bruno Calabretta spends much of his time researching Cancer research, Stem cell, Transcription factor, Cell biology and Leukemia. Bruno Calabretta does research in Cancer research, focusing on Myeloid leukemia specifically. His Stem cell research includes elements of Autophagy, Chronic myelogenous leukemia and Imatinib mesylate.
His Cell biology research incorporates elements of Cell culture and K562 cells. His work in K562 cells addresses issues such as Ccaat-enhancer-binding proteins, which are connected to fields such as Molecular biology and Enhancer binding. His Molecular biology study incorporates themes from Transfection and Phosphorylation.
Bruno Calabretta mainly focuses on Cancer research, Stem cell, Myeloid leukemia, Molecular biology and Cancer cell. Bruno Calabretta mostly deals with Imatinib mesylate in his studies of Cancer research. His work carried out in the field of Stem cell brings together such families of science as Autophagy, Chronic myelogenous leukemia, Cellular differentiation and ABL.
His Molecular biology study combines topics in areas such as MYB, Protein stabilization and Cell biology. He works mostly in the field of Cell biology, limiting it down to topics relating to K562 cells and, in certain cases, CD34 and Haematopoiesis. His Cancer cell research focuses on Cancer stem cell and how it relates to breakpoint cluster region.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham.
Autophagy (2012)
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway
Tomasz Skorski;Alfonso Bellacosa;Margaret Nieborowska‐Skorska;Miroslaw Majewski.
The EMBO Journal (1997)
THE BIOLOGY OF CML BLAST CRISIS
Bruno Calabretta;Danilo Perrotti.
Blood (2004)
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.
Cristian Bellodi;Maria Rosa Lidonnici;Ashley Hamilton;G. Vignir Helgason.
Journal of Clinical Investigation (2009)
Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis.
Francesca Peruzzi;Marco Prisco;Michael Dews;Paolo Salomoni.
Molecular and Cellular Biology (1999)
Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
Tomasz Skorski;Palanisamy Kanakaraj;Margaret Nieborowska-Skorska;Mariusz Z. Ratajczak.
Blood (1995)
Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin
D Jaskulski;Jk deRiel;We Mercer;Bruno Calabretta.
Science (1988)
A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro
Alan M. Gewirtz;Bruno Calabretta.
Science (1988)
Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides
Cezary Szczylik;Tomasz Skorski;Nicholas C. Nicolaides;Livia Manzella.
Science (1991)
An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
Giovanni Anfossi;Alan M. Gewirtz;Bruno Calabretta.
Proceedings of the National Academy of Sciences of the United States of America (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
German Center for Neurodegenerative Diseases
University of Pennsylvania
Temple University
Instytut Biologii Doświadczalnej im. Marcelego Nenckiego
University of Modena and Reggio Emilia
Thomas Jefferson University
TriLink BioTechnologies (United States)
University of Glasgow
École Normale Supérieure de Lyon
Istituto Superiore di Sanità
Carnegie Mellon University
Khazar University
National Institute for Materials Science
IBM (United States)
University of Melbourne
China West Normal University
University of Guelph
Kobe University
London School of Hygiene & Tropical Medicine
University College Dublin
University of Florida
Spanish National Centre for Cardiovascular Research
University College London
Lund University
University College London
Université Paris Cité